Title: [Molecular dynamics simulation of the tubulin dimer with cytostatics].
Journal: Molekuliarnaia biologiia 20120101
Title: Gateways to clinical trials.
Journal: Methods and findings in experimental and clinical pharmacology 20101201
Title: Dose-finding and pharmacokinetic study of orally administered indibulin (D-24851) to patients with advanced solid tumors.
Journal: Investigational new drugs 20100401
Title: Gateways to clinical trials.
Journal: Methods and findings in experimental and clinical pharmacology 20100101
Title: Indolobenzazepin-7-ones and 6-, 8-, and 9-membered ring derivatives as tubulin polymerization inhibitors: synthesis and structure--activity relationship studies.
Journal: Journal of medicinal chemistry 20091008
Title: Synthesis and structure-activity relationships of N-aryl(indol-3-yl)glyoxamides as antitumor agents.
Journal: Bioorganic & medicinal chemistry 20090915
Title: Indibulin, a novel microtubule inhibitor, discriminates between mature neuronal and nonneuronal tubulin.
Journal: Cancer research 20090101
Title: Side chain modifications of (indol-3-yl)glyoxamides as antitumor agents.
Journal: Journal of enzyme inhibition and medicinal chemistry 20081001
Title: Design, synthesis and cytotoxicity of novel podophyllotoxin derivatives.
Journal: Chemical & pharmaceutical bulletin 20080601
Title: Indole- and indolizine-glyoxylamides displaying cytotoxicity against multidrug resistant cancer cell lines.
Journal: Bioorganic & medicinal chemistry letters 20080315
Title: In vivo evaluation of indolyl glyoxamides in the phenotypic sea urchin embryo assay.
Journal: Chemical biology & drug design 20071201
Title: Phase I dose-finding and pharmacokinetic trial of orally administered indibulin (D-24851) to patients with solid tumors.
Journal: Investigational new drugs 20070601
Title: Antirestenotic effects of a novel polymer-coated d-24851 eluting stent. Experimental data in a rabbit iliac artery model.
Journal: Cardiovascular and interventional radiology 20070101
Title: Microtubule inhibitor D-24851 induces p53-independent apoptotic cell death in malignant glioma cells through Bcl-2 phosphorylation and Bax translocation.
Journal: International journal of oncology 20050301
Title: Stable isotopically labeled internal standards in quantitative bioanalysis using liquid chromatography/mass spectrometry: necessity or not?
Journal: Rapid communications in mass spectrometry : RCM 20050101
Title: Quantitative analysis of D-24851, a novel anticancer agent, in human plasma and urine by liquid chromatography coupled with tandem mass spectrometry.
Journal: Rapid communications in mass spectrometry : RCM 20040101
Title: Differential roles of p21(Waf1) and p27(Kip1) in modulating chemosensitivity and their possible application in drug discovery studies.
Journal: Molecular pharmacology 20011101
Title: D-24851, a novel synthetic microtubule inhibitor, exerts curative antitumoral activity in vivo, shows efficacy toward multidrug-resistant tumor cells, and lacks neurotoxicity.
Journal: Cancer research 20010101
